Notice 16. 1 Any and all notices, statements, demands or other communications hereunder may be given by a party to the other by mail, facsimile, telegraph, messenger or otherwise to the address specified in Appendix I hereto, or so sent to such party at any other place specified in a notice of change of address hereafter received by the other. All notices, demands and requests hereunder may be made orally, to be confirmed promptly in writing, or by other communication as specified in the preceding sentence.
Notice 16. 1 Any notice or other communication to be given under this Agreement shall be in writing and addressed as follows: for the Company: GT Gain Therapeutics SA Xxx Xxxxxx Xxxx no. 9D 6900 Lugano, Switzerland for Xx. Xxxxxx Xxxxxxxx Via Cortivo 2, 6976 Lugano-Xxxxxxxxxx, Switzerland
Notice 16. 01 Method of Notice: All notices, demands or other communications required or desired to be given hereunder by any party shall be in writing and shall be validly given or made to the other parties if served personally on such other parties or if deposited in the United States mail, certified or registered, postage prepaid, return receipt requested. If such notice, demand or other communication be served personally, service shall be deemed made at the time of such personal service. If such notice, demand or other communication be given by mail, such notice shall be conclusively deemed given forty-eight (48) hours after the deposit thereof in the United States mail, addressed to the party to whom such notice, demand or other communication is to be given as hereinafter provided.
Notice 16. 1 Unless otherwise provided herein, all notices and communications concerning this Agreement shall be addressed to the other party as follows: If to QWEST: QWEST Communications Corporation ATTENTION: President 000 Xxxxxxxxxxx Xxxxxx Xxxxxx, Xxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 with a copy to: QWEST Communications Corporation ATTENTION: General Counsel 000 Xxxxxxxxxxx Xxxxxx Xxxxxx, Xxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 and a copy to: Xxxxxx Xxxxx Xxxx, Esq. Holme Xxxxxxx & Xxxx LLP 1700 Lincoln, Suite 4100 Xxxxxx, Xxxxxxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 If to FRONTIER: FRONTIER Communications International Inc. ATTENTION: Director, Network Development 000 Xxxxx Xxxxxxx Xxxxxx Xxxxxxxxx, Xxx Xxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 with a copy to: Frontier Corporation ATTENTION: Vice President, Network Planning and Development 000 Xxxxx Xxxxxxx Xxxxxx Xxxxxxxxx, Xxx Xxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 48 and a copy to: Frontier Corporation ATTENTION: Vice President, Legal and Regulation 000 Xxxxx Xxxxxxx Xxxxxx Xxxxxxxxx, Xxx Xxxx 00000 Telephone No.: (000) 000-0000 Facsimile No.: (000) 000-0000 or at such other address as either party may designated from time to time in writing to the other party.
Notice 16. Oznamování 16.1 Any notice or other communication given to a party under or in connection with this Appendix must be in writing and delivered to: 16.1 Veškerá oznámení nebo jiná sdělení poskytnutá smluvní straně podle této přílohy nebo v souvislosti s ní musí být učiněna písemně a doručena na adresu: For the Sponsor: Email: Pro zadavatele: Email: Contact person for personal data protection at Xxxxxxx Memorial Cancer Institute: , e-mail: Kontaktní osoba pro ochranu osobních údajů ve MOÚ: , e-mail: 16.2 16.1 does not apply to the service of any proceedings or other documents in any legal action or, where applicable, any arbitration or other method of dispute resolution. 16.2 Bod 16.1 se nevztahuje na provádění řízení nebo jiných dokumentů v rámci případného právního řízení nebo případně jakéhokoli rozhodčího řízení nebo jiného způsobu řešení sporů. Annex A to Data Processing Agreement: Personal Data processing purposes and details Doplněk A ke smlouvě o zpracování údajů: Účely zpracování osobních údajů a podrobnosti Subject matter of processing: Personal data will be collected by study site team members from patients medical records and study documentation worksheets. This data will be entered in a pseudonymized fashion into the study specific eCRF. Předmět zpracování: Osobní údaje budou shromažďovány členy týmu studijního pracoviště ze zdravotních záznamů pacientů a pracovních listů studijní dokumentace. Tyto údaje budou zadány pseudonymizovaným způsobem do eCRF specifického pro studii. Duration of Processing: Doba trvání zpracování: Personal data will be collected and processed according to the duration of the study as described in the study protocol. Osobní údaje budou shromažďovány a zpracovávány podle doby trvání studie, jak je popsáno v protokolu studie. Nature of Processing: Personal data which will be collected and processed in this study gathered from data presented in medical records and study documentation worksheet will then be entered to eCRF specific for the study. Povaha zpracování: Osobní údaje, které budou shromažďovány a zpracovávány v této studii a které budou shromážděny z údajů uvedených ve zdravotních záznamech a záznamovém listu studijní dokumentace, budou poté zadány do eCRF specifického pro studii. Business Purposes: Personal data which will be collected and processed in this study will be collected for the purpose of this study as specified per clinical study protocol. Obchodní účely: Osobní údaje, které budou shromažďovány a zpraco...
Notice 16
